Endothelial progenitor cells in the vascular pathophysiology of hypertension: Arterial stiffness, ageing and more

Journal of Human Hypertension

Volumn 20, Issue 7, 2006, Pages 475-477

  Boos, C J ^a   Goon, P K Y ^a   Lip, G Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT;

AGING; ANGIOGENESIS; ARTERY COMPLIANCE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HUMAN; HYPERTENSION; NOTE; PATHOPHYSIOLOGY; RISK FACTOR; STEM CELL;

AGING; ANTIGENS, CD34; BLOOD VESSELS; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; STEM CELLS;

EID: 33745253380     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001991     Document Type: Note

References (33)

1. Karter Y, Aydin S, Curgunlu A, Uzun H, Erturk N, Vehid S et al. Endothelium and angiogenesis in white coat hypertension. J Hum Hypertens 2004; 18: 809-814.
2. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: Is it an immutable cardiovascular risk factor? Hypertension 2005; 46: 454-462.
3. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005; 66: 286-294.
4. Giansante C, Fiotti N. Insights into human hypertension: The role of endothelial dysfunction. J Hum Hypertens 2005 [E-pub ahead of print: 29 September 2005; doi:10.1038/sj.jhh.1001951].
5. Nash MC, Wade AM, Shah V, Dillon MJ. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol 1996; 103: 167-170.
6. Boos CJ, Lip GY. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: A relationship between inflammation and hypertension? J Hum Hypertens 2005; 19: 511-513.
7. Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 2005; 18: 3S-10S.
8. Matsuoka O, Otsuka K, Murakami S, Hotta N, Yamanaka G, Kubo Y et al. Arterial stiffness independently predicts cardiovascular events in an elderly community-Longitudinal investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother 2005; 59: S40-S44.
9. Sutton-Tyrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384-3390.
10. Thuillez C, Richard V. Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens 2005; 19(Suppl 1): S21-S25.
11. Cockcroft JR, Wilkinson IB. Large arterial stiffness: An important therapeutic target. J Hum Hypertens 2000; 14: 533-535.
12. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA et al. Brachial-ankle pulse wave velocity: An index of central arterial stiffness? J Hum Hypertens 2005; 19: 401-406.
13. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005; 93: 228-235.
14. Hristov M, Weber C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004; 8: 498-508.
15. Tao J, Wang Y, Yang Z, Tu C, Wang JM, Guo MG. Circulating endothelial progenitor cell deficiency contributes to increased arterial elasticity in persons of advancing age. J Hum Hyper 2006 (in press).
16. Tao J, Jin YF, Yang Z, Wang LC, Gao XR, Lui L et al. Reduced arterial elasticity is associated with endothelial dysfunction in persons of advancing age: Comparative study of noninvasive pulse wave analysis and laser Doppler blood flow measurement. Am J Hypertens 2004; 17: 654-659.
17. Hill JM, Finkel T, Quyyumi AA. Endothelial progenitor cells and endothelial dysfunction. Vox Sang 2004; 87(Suppl 2): 31-37.
18. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
19. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2005 [E-pub ahead of print].
20. Kim JW, Park CG, Hong SJ, Park SM, Rha SW, Seo HS et al. Acute and chronic effects of cigarette smoking on arterial stiffness. Blood Press 2005; 14: 80-85.
21. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065.
22. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 2004; 95: 343-353.
23. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890.
24. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
25. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1441-1448.
26. Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005; 67: 1672-1676.
27. Ichihara A, Hayashi M, Koura Y, Tada Y, Kaneshiro Y, Saruta T. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens 2005; 19: 103-109.
28. Raison J, Rudnichi A, Safar ME. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: A preliminary study. J Hum Hypertens 2002; 16: 705-710.
29. Neutel JM. Effect of the renin-angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. J Hum Hypertens 2004; 18: 599-606.
30. Schram MT, van Ittersum FJ, Spoelstra-de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG et al. Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: Effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial. J Hum Hypertens 2005; 19: 429-437.
31. Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens 2005; 19: 551-557.
32. Magen E, Viskoper JR, Mishal J, Priluk R, London D, Yosefy C. Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects. J Hum Hypertens 2005; 19: 667-673.
33. Felmeden D, Nadar SK, Lip GYH. Aspirin and endothelial function in hypertension. J Hum Hypertens 2005; 19: 663-665.